Award

Diagnosis and remedy for mitochondria-related nephropathy

Description: Mitochondrial disease is one kind of intractable disease for which the diagnosis is still complicated by the distinct lack of sensitive and specific biomarkers and remedies.We reported that a new indole-derivative drug, MA-5, improved the cardiac and renal respiration and prolonged survival in diseas model mice carrying a deleted mitochondrial DNA mutation that makes it suitable for evaluating the phenotype of human mitochondrial diseases and renal diseases. In addition, mitochondrial disease is one kind of intractable disease for which the diagnosis is still complicated by the distinct lack of sensitive and specific biomarkers.We found the potential biomarkers for mitochondrial dysfunction to improve diagnoses and develop new medicines to ameliorate the mitochondrial diseases.
Amount: ¥17,550,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (B)
Start date: 2018-04-01
End date: 2021-03-31
Investigator: Abe Takaaki (lead)
Institution: Tohoku University
Funded outputs count: 10
Funder award ID: 18H02822
OpenAlex ID: G6404688958
2022 · Yasutoshi Akiyama, Shawn M. Lyons, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 9
2022 · Yasutoshi Akiyama, Shawn M. Lyons, et al. · Frontiers in Molecular Biosciences · 32
2019 · Eikan Mishima, Emiko Sato, et al. · Journal of the American Society of Nephrology · 199
2019 · Keigo Kanehara, Shinobu Ohnuma, et al. · Scientific Reports · 25
2019 · Koichi Kikuchi, Daisuke Saigusa, et al. · Nature Communications · 323
2018 · Takehiro Suzuki, Takaaki Abe · Kidney International · 9
2017 · Kaori Narumi, Eikan Mishima, et al. · The Nephron journals/Nephron journals · 14
2017 · Eikan Mishima, Shinji Fukuda, et al. · American Journal of Physiology-Renal Physiology · 112